推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Acta Pharmaceutica Sinica B 期刊收藏夹

2025年3月最新中科院分区数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 ACTA PHARM SIN 最新评论:您好,我投acta pharmaceutica sinica b 审稿一个月 状态变为required reviews completed已经一周多了,这是设呢么情况呢?按说... (2025-03-26)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐:
SCI论文AI润色+人工QC服务
IF2.9,JCR Q2肿瘤学期刊征稿中
赛默飞基础学科研究有奖问卷
同行专家帮助选刊
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Acta Pharmaceutica Sinica B期刊基本信息Hello,您是该期刊的第224506位访客

基本信息 登录收藏
期刊名字Acta Pharmaceutica Sinica BActa Pharmaceutica Sinica B

ACTA PHARM SIN B
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.3
85人评分
我要评分

声誉
8.9

影响力
7.7

速度
8.5

期刊ISSN2211-3835
微信扫码收藏此期刊
E-ISSN2211-3843
2023-2024最新影响因子
(数据来源于搜索引擎)
14.8 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日:14.47
2023-2024自引率6.10%点击查看自引率趋势图
五年影响因子14.1
JCI期刊引文指标 3.61
h-index 28
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
22.403.0352.253
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:General Pharmacology, Toxicology and Pharmaceutics
Q11 / 80

期刊简介
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association
Peer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association

Acta Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.

APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chineses Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.
期刊官方网站https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/apsb/default.aspx
作者指南网址https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/publish/guide-for-authors
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Acta Pharmaceutica Sinica B的语言要求,还能让Acta Pharmaceutica Sinica B编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Acta Pharmaceutica Sinica B编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( Full Length Articles and Reviews - USD2600; Short Articles - USD2000; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:pharmaceutical science、traditional chinese medicine、pharmaceutics、pharmaceutical chemistry、pharmacokinetics
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES, C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, PEOPLES R CHINA, 10005
出版商Elsevier BV
涉及的研究方向Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
出版国家或地区CHINA MAINLAND
出版语言English
出版周期Monthly
出版年份2011
年文章数 300点击查看年文章数趋势图
Gold OA文章占比98.22%
研究类文章占比:
文章 ÷(文章 + 综述)
76.00%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ15/354
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ12/354
中国科学院《国际期刊预警
名单(试行)》名单
2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2025年3月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区1区4区
PHARMACOLOGY & PHARMACY
药学
3区3区1区
中国科学院SCI期刊分区
2023年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区1区
PHARMACOLOGY & PHARMACY
药学
1区4区1区
中国科学院SCI期刊分区
2022年12月旧的升级版
大类学科小类学科Top期刊综述期刊
化学 2区1区1区
PHARMACOLOGY & PHARMACY
药学
2区3区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835%5BISSN%5D
平均审稿速度期刊官网数据:
平均Submission to first decision: 8 days; Review time: 36 days; Submission to Accept: 134 days; Acceptance to publication: 7 days;
网友分享经验:
19 Weeks
平均录用比例网友分享经验:

来源Elsevier官网:
9%
版面费/APC文章处理费信息
文章处理费:需要( Full Length Articles and Reviews - USD2600; Short Articles - USD2000; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Acta Pharmaceutica Sinica B顺利发表。
快看看作者怎么说吧:服务好评(2篇) 论文致谢
提交文稿
编辑信息 Editor-in-Chief
Jian-Dong Jiang
Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Materia Medica, Beijing, China

Co-Editor-in-Chief
Rui Wang
China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China

Associate Editors-in-Chief
Xin-Xin Ding
The University of Arizona, Tucson, Arizona, United States of America

Shi-lin Chen
China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China

Wen-Xing Ding
University of Kansas Medical Center, Kansas City, Kansas, United States of America

De-An Guo
China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China

Hongmin Li
The University of Arizona College of Medicine Phoenix, Phoenix, Arizona, United States of America

Rong-Guang Shao
Chinese Academy of Medical Sciences Institute of Medicinal Biotechnology and Peking Union Medical College, Beijing, China

Jian-Gong Shi
China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica and Peking Union Medical College, Beijing, China

Duxin Sun
University of Michigan College of Pharmacy, Ann Arbor, Michigan, United States

Xiao-Liang Wang
China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica and Peking Union Medical College, Beijing, China

Wen Xie
University of Pittsburgh, School of Pharmacy, Department of Pharmaceutical Sciences, Pittsburgh, Pennsylvania, United States of America

Jian-Ping Ye
Shanghai Institute of Diabetes, Shanghai, China

Jianhua Zhang
The University of Alabama at Birmingham, Birmingham, Alabama, United States of America

Haining Zhu
The University of Arizona College of Pharmacy, Tucson, Arizona, United States of America

Qiang Zhang
Peking University School of Pharmaceutical Sciences, Beijing, China
期刊常用信息链接
同领域相关期刊 Acta Pharmaceutica Sinica B期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Acta Pharmaceutica Sinica B中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Acta Pharmaceutica Sinica B上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Antibiotics-Basel07.30
    Pharmacology Research & Perspectives05.30
    Therapeutics and Clinical Risk Management05.30
    Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy372.60
    Infarma Pharmaceutical Sciences00.10
    Mental Health Clinician01.90
    Pharmacological Research Modern Chinese Medicine01.60
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE732770
    BIOMATERIALS607083
    BIOMEDICINE & PHARMACOTHERAPY600353
    Frontiers in Pharmacology565661
    COMPUTERS IN BIOLOGY AND MEDICINE550545
    Frontiers in Immunology550319
    JOURNAL OF ETHNOPHARMACOLOGY536752
    Frontiers in Oncology486683
    COLLOIDS AND SURFACES B-BIOINTERFACES466134
    Acta Biomaterialia455590
  •  

    Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Unlocking the role of wound microbiome in diabetic, burn, and germ-free wound repair treated by natural and synthetic scaffolds

    Author: Xu, Zeyu; Zhang, Lixiang; Tang, Qinghan; Yang, Chenxi; Ding, Xiaotong; Wang, Ziyu; Huang, Rizhong; Jiang, Ruihan; Maitz, Joannake; Shi, Huaikai; Yan, Xin; Dong, Mei; Chen, Jun; Wang, Yiwei
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 611-626. DOI: 10.1016/j.apsb.2024.08.024
        DOI
    2.Iron and siRNA co-encapsulated ferritin nanocages induce ferroptosis synergistically for cancer therapy

    Author: Liu, Danni; Wang, Yaoqi; Sun, Qi; Mei, Dong; Wang, Xiaoling; Su, Yan; Zhang, Jie; Huo, Ran; Tian, Yang; Liu, Siyu; Zhang, Shuang; Cui, Chunying
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 526-541. DOI: 10.1016/j.apsb.2024.10.006
        DOI
    3.Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-c] pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer

    Author: Li, Yang; Fang, Yan; Chen, Xiaoyu; Tong, Linjiang; Feng, Fang; Zhou, Qianqian; Chen, Shulun; Ding, Jian; Xie, Hua; Zhang, Ao
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 438-466. DOI: 10.1016/j.apsb.2024.10.002
        DOI
    4.Regulation of histidine metabolism by Lactobacillus Reuteri mediates the pathogenesis and treatment of ischemic stroke

    Author: Hu, Kangrui; Zhou, Zhihao; Li, Haofeng; Xiao, Jijun; Shen, Yun; Ding, Ke; Zhang, Tingting; Wang, Guangji; Hao, Haiping; Liang, Yan
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 239-255. DOI: 10.1016/j.apsb.2024.10.003
        DOI
    5.Dimeric natural product panepocyclinol A inhibits STAT3 via di-covalent modification

    Author: Li, Li; Wang, Yuezhou; Wang, Yiqiu; Li, Xiaoyang; Deng, Qihong; Gao, Fei; Lian, Wenhua; Li, Yunzhan; Gui, Fu; Wei, Yanling; Zhu, Su-Jie; Yun, Cai-Hong; Zhang, Lei; Hu, Zhiyu; Xu, Qingyan; Wu, Xiaobing; Chen, Lanfen; Zhou, Dawang; Zhang, Jianming; Xia, Fei; Deng, Xianming
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 409-423. DOI: 10.1016/j.apsb.2024.10.001
        DOI
    6.Cerebral endothelial 3-mercaptopyruvate sulfurtransferase improves ischemia-induced cognitive impairment via interacting with protein phosphatase 2A

    Author: Zhu, Li; Huang, Yi; Jin, Jing; Zou, Rongjun; Zuo, Rui; Luo, Yong; Song, Ziqing; Dai, Linfeng; Zhang, Minyi; Chen, Qiuhe; Wang, Yunting; Wang, Wei; He, Rongrong; Chen, Yang
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 314-330. DOI: 10.1016/j.apsb.2024.11.015
        DOI
    7.Caffeic acid-vanadium nanozymes treat skin flap ischemia-reperfusion injury through macrophage reprogramming and the upregulation of X-linked inhibitors of apoptotic proteins

    Author: Zhao, Xinyu; Shan, Jie; Qian, Hanying; Jin, Xu; Sun, Yiwei; Xing, Jianghao; Li, Qingrong; Chen, Xu-Lin; Wang, Xianwen
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 592-610. DOI: 10.1016/j.apsb.2024.08.022
        DOI
    8.Drug discovery targeting thyroid hormone receptor f3 (THRf3) for the treatment of liver diseases and other medical indications

    Author: Wang, Kean; Chen, Feiyang; Wang, Jiang; Liu, Hong
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 35-51. DOI: 10.1016/j.apsb.2024.07.025
        DOI
    9.GSFM: A genome-scale functional module transformation to represent drug efficacy for in silico drug discovery

    Author: Tian, Saisai; Liao, Xuyang; Cao, Wen; Wu, Xinyi; Chen, Zexi; Lu, Jinyuan; Wang, Qun; Zhang, Jinbo; Chen, Luonan; Zhang, Weidong
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 133-150. DOI: 10.1016/j.apsb.2024.08.017
        DOI
    10.Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis

    Author: Lu, Yuan; Wang, Shan-Shan; Li, Meng-Ya; Liu, Rong; Zhu, Meng-Fan; Yang, Liang-Mei; Wang, Feng-Yang; Huang, Ke-Bin; Liang, Hong
    Journal: ACTA PHARMACEUTICA SINICA B. 2025; Vol. 15, Issue 1, pp. 424-437. DOI: 10.1016/j.apsb.2024.06.017
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    MMWR Recommendations and Reports036.00
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386173.60
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Materials61119.40
    Nature Reviews Disease Primers4876.70
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共232


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室